We just posted an abstract of a CareCyte proposal to the incoming healthcare team, on their website, and we have put the abstract and a more detailed version of the proposal into the CareCyte website and blog. Take a look and leave us a comment on the CareCyte Blog about what you think about what we are attempting to do.
I have had severe gum disease since I was in my late 20s. I brought it on with a combination of poor home care and smoking. I have evidence that 0steoporosis and some poor orthodontia contributed to my difficulties. Of course, as a dutiful son, I held my mother responsible. She always got a laugh out of that.
Along the way I have discovered that a lot of people suffer with difficulties with oral health – cavities or periodontal disease. The published numbers say that more than 5% of those over 35 have moderate gum disease. By the time you get to my age, more than 10% of the population have at least moderate gum disease.
The real problem is some wicked little bacteria that like to live in pockets and create mischief in our mouths. And, recent research has shown, that mischief in our mouths can contribute to even more serious difficulties in other parts of the body, including the heart.
Some friends of mine have developed and just released a probiotic product that puts into the mouth a combination of “good bacteria” which, when ingested as directed (and alongside appropriate home care) will effectively eliminate gum disease and dental caries. Side effects that they promise include fresh breath and whiter teeth….
I have just ordered my first supply of the product, EvoraPlus from ONI Biopharma, Inc. They have an offer where if you set up automatic reorders they pay shipping. In a few weeks or months this product will be available in your local Drugstore.
If you have any concerns at all about the health of your mouth, your teeth, or your gums, I recommend you join me in using this product.
Full disclosure: Stanley Stein, the CEO of ONI BioPharma, is chief strategist for CareCyte, and I serve on the board of directors of ONI BioPharma’s Mexican subsidiary.
My friend Alan Solinger alerted me to this striking story. One of the world’s best violinists, dressed as a street person, played for 45 minutes in a Washington DC Metro station during rush hour. No one recognized him. He collected some tips, and the most interested listener may have been a small child. No one stopped and really listened. Read the whole story. It’s amazing. What conclusions would you draw about the way we listen in our world today?